"10.1371_journal.pgen.1005050","plos genetics","2015-03-06T00:00:00Z","Christine R Beck; Claudia M B Carvalho; Linda Banser; Tomasz Gambin; Danielle Stubbolo; Bo Yuan; Karen Sperle; Suzanne M McCahan; Marco Henneke; Pavel Seeman; James Y Garbern; Grace M Hobson; James R Lupski","Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America; Centro de Pesquisas Rene Rachou- FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil; Nemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States of America; Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany; Department of Pediatric Neurology, DNA Laboratory, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic; University of Rochester Medical Center, Rochester, New York, United States of America; University of Delaware, Department of Biological Sciences, Newark, Delaware, United States of America; Department of Pediatrics and Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States of America; Texas Childrens Hospital, Houston, Texas, United States of America","Conceived and designed the experiments: CRB CMBC LB GMH JRL. Performed the experiments: CRB CMBC LB DS BY KS. Analyzed the data: CRB CMBC LB TG DS SMM. Contributed reagents/materials/analysis tools: MH PS JYG SMM. Wrote the paper: CRB CMBC LB GMH JRL.","JRL has stock ownership in 23andMe, Ion Torrent Systems, and Lasergen, Inc., is a paid consultant for Regeneron Pharmaceuticals and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the chromosomal microarray analysis (CMA) and clinical exome sequencing offered in the Medical Genetics Laboratory (MGL; http://www.bcm.edu/geneticlabs/). GMH receives pay and the Nemours Biomedical Research department derives revenue from the Molecular Diagnostics Laboratory, Alfred I. duPont Hospital for Children for diagnostic testing. Other authors have no disclosures relevant to the manuscript.","2015","03","Christine R Beck","CRB",13,TRUE,5,6,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
